Publications by the researcher in collaboration with José Enrique Piñero Barroso (42)

2025

  1. Dehydrothyrsiferol Against Cutaneous Leishmaniasis: Treatment Outcome in a Murine Model

    Marine Drugs, Vol. 23, Núm. 1

  2. Infectious disease risk after the October 2024 flash flood in Valencia, Spain: Disaster evolution, strategic scenario analysis, and extrapolative baseline for a One Health assessment

    One Health, Vol. 21

  3. Laurequinone-based synthetic quinones as agents against Leishmania amazonensis

    Bioorganic Chemistry, Vol. 164

  4. Mechanism Insight of Cell Death Signaling by Thymol Derivatives on Trypanosomatidae Protozoan Parasites

    Antibiotics, Vol. 14, Núm. 4

  5. Repurposing Analysis of Nitroxoline (8-Hydroxy-5-nitroquinoline) as an Antichagasic Compound

    Pharmaceuticals, Vol. 18, Núm. 8

  6. Repurposing COVID-19 Compounds (via MMV COVID Box): Almitrine and Bortezomib Induce Programmed Cell Death in Trypanosoma cruzi

    Pathogens, Vol. 14, Núm. 2

  7. Standardized Artemisia annua Exhibits Dual Antileishmanial Activity and Immunomodulatory Potential In Vitro

    Veterinary Sciences, Vol. 12, Núm. 10

  8. Unlocking withaferin-A: Structural design toward next-generation antikinetoplastid agents

    Biomedicine and Pharmacotherapy, Vol. 192

2024

  1. Acrylonitrile derivatives: In vitro activity and mechanism of cell death induction against Trypanosoma cruzi and Leishmania amazonensis

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 24

  2. Anti-COVID Drugs (MMV COVID Box) as Leishmanicidal Agents: Unveiling New Therapeutic Horizons

    Pharmaceuticals, Vol. 17, Núm. 3

  3. E-Cyanoacrylamides and 5-Imino Pyrrolones against Trypanosoma cruzi: Activity and Induced Mechanisms of Cell Death

    Tropical Medicine and Infectious Disease, Vol. 9, Núm. 9

  4. Global Health Priority Box: Discovering Flucofuron as a Promising Antikinetoplastid Compound

    Pharmaceuticals, Vol. 17, Núm. 5

  5. In Vivo Evaluation of Sepigel-Based Meglumine Antimoniate and Amphotericin B for Cutaneous Leishmaniasis Treatment

    Pathogens, Vol. 13, Núm. 8

  6. Salvadoran Celastraceae Species as a Source of Antikinetoplastid Quinonemethide Triterpenoids

    Plants, Vol. 13, Núm. 3

  7. Staurosporine as a Potential Treatment for Acanthamoeba Keratitis Using Mouse Cornea as an Ex Vivo Model

    Marine Drugs, Vol. 22, Núm. 9

2023

  1. In vitro activity and mechanism of cell death induction of cyanomethyl vinyl ethers derivatives against Trypanosoma cruzi

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 22, pp. 72-80

  2. Laurequinone, a Lead Compound against Leishmania

    Marine Drugs, Vol. 21, Núm. 6

  3. Meroterpenoids from Gongolaria abies-marina against Kinetoplastids: In Vitro Activity and Programmed Cell Death Study

    Pharmaceuticals, Vol. 16, Núm. 4

  4. Multi-target withaferin-A analogues as promising anti-kinetoplastid agents through the programmed cell death

    Biomedicine and Pharmacotherapy, Vol. 164

  5. Withaferin A-silyl ether analogs as potential anti-kinetoplastid agents targeting the programmed cell death

    Biomedicine and Pharmacotherapy, Vol. 157